highly significantp = 0.0004
1.31 ± 0.99 mg/mL, respectively; p = 0.1016), with a highly significant increase on day 3 taking into consideration the baseline status ( p = 0.0004) ( Table 2 ).
1.31 ± 0.99 mg/mL, respectively; p = 0.1016), with a highly significant increase on day 3 taking into consideration the baseline status ( p = 0.0004) ( Table 2 ).